Penserra Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Penserra Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33K	Buy	+140	New	+$30.7K	﹤0.01%	839
2025 Q1	–	Sell	-537	Closed	-$66K	–	1119
2024 Q4	$66K	Hold	537	–	–	﹤0.01%	906
2024 Q3	$59K	Sell	537 -36	-6%	-$3.94K	﹤0.01%	838
2024 Q2	$61K	Buy	573 +20	+4%	+$2.2K	﹤0.01%	865
2024 Q1	$66K	Hold	553	–	–	﹤0.01%	853
2023 Q4	$68K	Hold	553	–	–	﹤0.01%	949
2023 Q3	$71K	Sell	553 -12,500	-96%	-$1.67M	﹤0.01%	949
2023 Q2	$1.62M	Buy	13,053 +101	+0.8%	+$13.6K	0.03%	322
2023 Q1	$1.9M	Sell	12,952 -2,598	-17%	-$384K	0.04%	345
2022 Q4	$2.48M	Buy	15,550 +4,970	+47%	+$728K	0.05%	332
2022 Q3	$1.41M	Sell	10,580 -1,500	-12%	-$228K	0.04%	321
2022 Q2	$1.88M	Buy	12,080 +582	+5%	+$89.6K	0.05%	302
2022 Q1	$1.79M	Sell	11,498 -6,746	-37%	-$979K	0.04%	356
2021 Q4	$2.32M	Sell	18,244 -3,104	-15%	-$408K	0.05%	344
2021 Q3	$2.78M	Sell	21,348 -51,586	-71%	-$7.79M	0.06%	304
2021 Q2	$13M	Buy	+72,934	New	+$12.6M	0.24%	139
2018 Q3	–	Sell	-12,809	Closed	-$2.21M	–	722
2018 Q2	$2.21M	Buy	+12,809	New	+$2.09M	0.14%	114
2017 Q1	–	Sell	-164	Closed	-$17K	–	706
2016 Q4	$17K	Buy	164 +34	+26%	+$3.79K	﹤0.01%	702
2016 Q3	$15K	Buy	130 +52	+67%	+$7.01K	﹤0.01%	718
2016 Q2	$11K	Buy	78 +29	+59%	+$4.28K	﹤0.01%	584
2016 Q1	$6K	Buy	49 +15	+44%	+$1.87K	﹤0.01%	679
2015 Q4	$5K	Buy	+34	New	+$4.71K	﹤0.01%	814

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Penserra Capital Management's JAZZ Position: Q2 2026 in Review

Penserra Capital Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 140 shares worth $33K. The stake represents ﹤0.01% of the portfolio and ranks #839 among its holdings. This is a return to the name: Penserra Capital Management previously reported a position in JAZZ as recently as Q4 2024.

Penserra Capital Management first reported a position in JAZZ in Q4 2015 and has held it in 22 quarters since. The position peaked at $13M in Q2 2021. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Penserra Capital Management held 140 shares of Jazz Pharmaceuticals worth $33K as of Q2 2026.
Jazz Pharmaceuticals was a new Penserra Capital Management position in Q2 2026.
Jazz Pharmaceuticals made up ﹤0.01% of Penserra Capital Management's portfolio in Q2 2026, its #839 holding.
Penserra Capital Management first reported a position in Jazz Pharmaceuticals in Q4 2015 and has held it in 22 quarters since.
Penserra Capital Management's Jazz Pharmaceuticals position peaked at $13M in Q2 2021.
647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.